Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11) Research & Development: R$0.00 Mil (TTM As of Dec. 2024)


BSP:HUSC11 Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba BSP:HUSC11
44 GF Score
Price R$96.01
GF Value R$33.29
! 3 Warning Signs
View Full Analysis

What is Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Research & Development?

Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba BSP:HUSC11 44 Research & Development is R$0.00 Mil as of Dec. 2024. GuruFocus rates BSP:HUSC11 with a GF Score™ of 44/100 and a GF Value™ of R$33.29. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's Research & Development for the six months ended in Dec. 2024 was R$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was R$0.00 Mil.

Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba  (BSP:HUSC11) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Research & Development Related Terms

Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Research & Development Historical Data

* Premium members only.

The historical data trend for Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Research & Development Chart

Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
BSP:HUSC11
44GF Score
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba BSP:HUSC11
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was R$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of R$0.00 Mil mean?
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11) has a Research & Development of R$0.00 Mil as of Dec. 2024. Research and development expense is the total cost for research and development activities. View historical data on Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba and its competitors.
Is Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's Research & Development too high?
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's current Research & Development is R$0.00 Mil. Overall, Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's Research & Development compare to WELL and VTR?
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's Research & Development of R$0.00 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a REITs company?
A good Research & Development depends on the REITs industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba and its competitors. Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's current Research & Development is R$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba stock overvalued right now?
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11) has a current Research & Development of R$0.00 Mil. The stock's GF Value™ is R$33.29, compared to a current price of R$96.01 — trading 188.4% above its estimated fair value. The current Research & Development is R$0.00 Mil. Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11), the current Research & Development is R$0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11) Overvalued in 2026?

Based on GuruFocus' analysis, Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba stock appears to be overvalued. The current stock price of R$96.01 is trading 188.4% above its estimated GF Value™ of R$33.29.

Key valuation signals for BSP:HUSC11:

  • Research & Development: R$0.00 Mil
  • GF Value™: R$33.29 vs. price of R$96.01 (188.4% above fair value)
  • GF Score™: 44/100 with 3 warning signs

No single metric tells the full story. See the BSP:HUSC11 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Business Description

Industry Real EstateREITs
Address Avenue Chedid Jafet, 222, Bloco B, 3rd Floor, Sao Paulo, BRA, 04511-065
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba is a closed-end fud.
44GF Score

Get the complete analysis for BSP:HUSC11

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$96.01
Price
R$33.29
GF Value